Drugs & TargetsFree EMA grants positive opinion to Adcetris combination in lymphoma indication April 03, 2020Vol.46 No.14
Drugs & TargetsFree China accepts sNDA for Zejula in ovarian cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree The U.K. removes Keytruda from Cancer Drug Fund in bladder cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree FDA approves Herzuma, equivalent of Herceptin, in indications March 20, 2020Vol.46 No.12
Drugs & TargetsFree FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma March 13, 2020Vol.46 No.11
Drugs & TargetsFree FDA accepts BLA for biosimilar MYL-1402O in cancer indications March 13, 2020Vol.46 No.11
Drugs & TargetsFree FDA grants Breakthrough Therapy Designation for JNJ-6372 in NSCLC indication March 13, 2020Vol.46 No.11
Drugs & TargetsFree Thermo Fisher Scientific collaborates with Janssen to co-develop companion diagnostic for cancer March 13, 2020Vol.46 No.11
Drugs & TargetsFree European Commission approves Venclyxto in CLL indication March 13, 2020Vol.46 No.11
